ARKG 02/16/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
102/16/2024CRISPR THERAPEUTICS AGCRSPH171821088.14%1,863,070 (0) (0%)$157,392,153.60
202/16/2024EXACT SCIENCES CORPEXAS30063P1056.47%2,046,629 (-26,704) (-1.29%)$125,028,565.60
302/16/2024TWIST BIOSCIENCE CORPTWST90184D1006.05%2,819,571 (0) (0%)$117,012,196.50
402/16/2024RECURSION PHARMACEUTICALS-ARXRX75629V1045.89%9,158,110 (0) (0%)$113,835,307.30
502/16/2024TELADOC HEALTH INCTDOC87918A1054.40%3,939,223 (0) (0%)$85,126,609.03
602/16/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1004.21%52,471,364 (0) (0%)$81,330,614.20
702/16/2024SCHRODINGER INCSDGR80810D1034.15%2,704,562 (0) (0%)$80,325,491.40
802/16/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1084.11%11,929,563 (0) (0%)$79,570,185.21
902/16/2024ACCOLADE INCACCD00437E1024.10%6,026,616 (0) (0%)$79,189,734.24
1002/16/2024BEAM THERAPEUTICS INCBEAM07373V1053.94%2,308,405 (0) (0%)$76,223,533.10
1102/16/202410X GENOMICS INC-CLASS ATXG88025U1093.63%1,458,759 (2,891) (0.2%)$70,122,545.13
1202/16/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.58%1,815,020 (0) (0%)$69,315,613.80
1302/16/2024IONIS PHARMACEUTICALS INCIONS4622221003.56%1,518,815 (-17,103) (-1.11%)$68,771,943.20
1402/16/2024INTELLIA THERAPEUTICS INCNTLA45826J1053.37%2,288,501 (6,395) (0.28%)$65,153,623.47
1502/16/2024CAREDX INCCDNA14167L1032.77%6,298,460 (0) (0%)$53,536,910.00
1602/16/2024VERACYTE INCVCYT92337F1072.65%2,026,404 (0) (0%)$51,268,021.20
1702/16/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.32%105,144 (0) (0%)$44,821,835.76
1802/16/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.32%11,348,878 (0) (0%)$44,941,556.88
1902/16/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.32%200,890 (0) (0%)$44,910,968.40
2002/16/2024VERVE THERAPEUTICS INCVERV92539P1012.09%3,045,048 (0) (0%)$40,438,237.44
2102/16/2024STANDARD BIOTOOLS INCLAB34385P1081.81%14,004,555 (0) (0%)$35,011,387.50
2202/16/2024UIPATH INC – CLASS APATH90364P1051.72%1,298,082 (0) (0%)$33,321,764.94
2302/16/2024MODERNA INCMRNA60770K1071.71%363,384 (0) (0%)$33,118,817.76
2402/16/2024908 DEVICES INCMASS65443P1021.52%3,804,616 (0) (0%)$29,371,635.52
2502/16/2024NURIX THERAPEUTICS INCNRIX67080M1031.44%2,829,352 (0) (0%)$27,869,117.20
2602/16/2024INCYTE CORPINCY45337C1021.44%471,161 (0) (0%)$27,784,364.17
2702/16/2024PRIME MEDICINE INCPRME74168J1011.32%3,266,948 (633,980) (24.08%)$25,482,194.40
2802/16/2024QUANTUM-SI INCQSI74765K1051.28%13,713,750 (0) (0%)$24,684,750.00
2902/16/2024COMPASS PATHWAYS PLCCMPS20451W1011.27%2,321,104 (0) (0%)$24,650,124.48
3002/16/2024REGENERON PHARMACEUTICALSREGN75886F1071.11%22,397 (0) (0%)$21,383,087.81
3102/16/2024REPARE THERAPEUTICS INCRPTX7602731021.04%2,904,442 (0) (0%)$20,185,871.90
3202/16/2024NVIDIA CORPNVDA67066G1040.90%23,882 (-1,969) (-7.62%)$17,352,183.56
3302/16/2024CERUS CORPCERS1570851010.77%6,195,820 (0) (0%)$14,808,009.80
3402/16/2024BUTTERFLY NETWORK INCBFLY1241551020.71%12,131,064 (0) (0%)$13,708,102.32
3502/16/2024AMGEN INCAMGN0311621000.66%44,150 (0) (0%)$12,762,440.50
3602/16/2024GUARDANT HEALTH INCGH40131M1090.44%387,836 (0) (0%)$8,582,810.68
3702/16/2024PERSONALIS INCPSNL71535D1060.38%5,621,395 (0) (0%)$7,420,241.40
3802/16/2024PFIZER INCPFE7170811030.18%123,488 (0) (0%)$3,397,154.88
3902/16/2024ABSCI CORPABSI00091E1090.12%464,191 (0) (0%)$2,390,583.65
4002/16/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.06%1,222,007 (413,470) (51.14%)$1,222,006.76
4102/16/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,734,826 (0) (0%)$737,301.05
4202/16/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$103,475.18
4302/16/2024INVITAE CORPNVTA46185L1030.00%3,920 (0) (0%)$71.74
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment